Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-02-15
2011-02-15
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253060, C514S253070, C544S363000
Reexamination Certificate
active
07888362
ABSTRACT:
The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.
REFERENCES:
patent: 4234584 (1980-11-01), Lattrell et al.
patent: 4831031 (1989-05-01), Lowe, III et al.
patent: 4883795 (1989-11-01), Lowe, III et al.
patent: 5436246 (1995-07-01), Bernotas et al.
patent: 6214829 (2001-04-01), Feenstra et al.
patent: 0 367 141 (1990-05-01), None
patent: 0 512 525 (1992-11-01), None
patent: 0 732 332 (1996-09-01), None
patent: 0 934 932 (1999-08-01), None
patent: 1 188 747 (2002-03-01), None
patent: 56-49361 (1981-05-01), None
patent: WO 91/00863 (1991-01-01), None
patent: WO 94/06789 (1994-03-01), None
patent: WO 96/22290 (1996-07-01), None
patent: WO 98/07703 (1998-02-01), None
patent: WO 00/71517 (2000-11-01), None
patent: WO 02/066469 (2002-08-01), None
patent: WO 2004/026864 (2004-01-01), None
patent: WO 2004/026864 (2004-04-01), None
patent: WO 2004/029048 (2004-04-01), None
patent: WO 2005/019215 (2005-03-01), None
Harrison et al., “Aripiprazole: A Review of Its Use in Schizophrenia and Schizoaffective Disorder”, ADIS Drug Evaluation, Drugs, vol. 64, No. 15, pp. 1715-1736, (2004).
Ishigooka et al., “Trends in the Clinical Development of the Second Generation Antipsychotics”, Rinsho-Seishin-Yakuri, (Japanese Journal of Clinical Psychopharmacology), vol. 4, pp. 1653-1664, (2001).
Murasaki et al., “The Prospect of New Pharmacological Treatment Against Psychiatric Disorders”, Rinsho-Seishin-Yakuri, (Japanese Journal of Clinical Psychopharmacology), vol. 1, pp. 5-22, (1998).
Pullar et al., “LY367265, An Inhibitor of the 5-Hydroxytryptamine Transporter and 5-Hydroxytryptamine2AReceptor Antagonist: A Comparison With the Antidepressant, Nefazodone”, European Journal of Pharmacology, vol. 407, pp. 39-46, (2000).
Meltzer et al, “Serotonin Receptors: Their Key Role in Drugs to Treat Schizophrenia”, Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 27, pp. 1159-1172, (2003).
Svensson, “α-Adrenoceptor Modulation Hypothesis of Antipsychotic Atypicality”, Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 27, pp. 1145-1158, (2003).
Oshiro et al., “Novel Antipsychotic Agents With Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-Piperazinyl/Butoxy]-3,4-Dihydro-2(1H)-Quinolinone Derivatives”, J. Med. Chem., vol. 41, pp. 658-667, (1998).
Moloney et al., “Synthesis and Serotonergic Activity of Variously Substituted (3-Amido)Phenylpiperazine Derivatives and Benzothiophene-4-Piperazine Derivatives: Novel Antagonists for the Vascular 5-HT1BReceptor”, European Journal of Medicinal Chemistry, vol. 39, pp. 305-321, (2004).
Toru et al., “Creativity in the Development of the Drug, Aripiprazole : A Novel Partial Dopamine D2Receptor Agonist for the Treatment of Schizophrenia”, Seishin-Igaku, (Psychiatry), vol. 46, pp. 855-864, (2004).
Kikuchi et al., “Aripiprazole, A Novel Antipsychotic—A Dopamine D2Partial Agonist”, Nou-no-Kagaku, (Brain Science), vol. 25, pp. 579-583, (2003).
Ito Nobuaki
Kuroda Hideaki
Matsubara Jun
Miyamura Shin
Oshima Kunio
Bernhardt Emily
Finnegan Henderson Farabow Garrett & Dunner LLP
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Piperazine-substituted benzothiophenes for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine-substituted benzothiophenes for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine-substituted benzothiophenes for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2644512